Discovery of Potent Dual EGFR/HER2 Inhibitors Based on Thiophene Scaffold Targeting H1299 Lung Cancer Cell Line.

MLA

Elrayess, Ranza, et al. “Discovery of Potent Dual EGFR/HER2 Inhibitors Based on Thiophene Scaffold Targeting H1299 Lung Cancer Cell Line.” Pharmaceuticals (14248247), vol. 14, no. 1, Jan. 2021, p. 9. EBSCOhost, https://doi.org/10.3390/ph14010009.

APA

Elrayess, R., Abdel Aziz, Y. M., Elgawish, M. S., Elewa, M., Yassen, A. S. A., Elhady, S. S., Elshihawy, H. A., & Said, M. M. (2021). Discovery of Potent Dual EGFR/HER2 Inhibitors Based on Thiophene Scaffold Targeting H1299 Lung Cancer Cell Line. Pharmaceuticals (14248247), 14(1), 9. https://doi.org/10.3390/ph14010009

Chicago

Elrayess, Ranza, Yasmine M. Abdel Aziz, Mohamed Saleh Elgawish, Marwa Elewa, Asmaa S. A. Yassen, Sameh S. Elhady, Hosam A. Elshihawy, and Mohamed M. Said. 2021. “Discovery of Potent Dual EGFR/HER2 Inhibitors Based on Thiophene Scaffold Targeting H1299 Lung Cancer Cell Line.” Pharmaceuticals (14248247) 14 (1): 9. doi:10.3390/ph14010009.